Yield10 Bioscience Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2003
Net Income	-14.46	-13.57	-11.03	-10.21	-12.96	-9.19	-10.82	-7.6	-23.68	-29.53	Upgrade
Depreciation & Amortization	0.6	0.66	0.58	0.61	1.83	0.78	0.21	0.52	0.27	0.51	Upgrade
Share-Based Compensation	1.59	1.9	1.68	0.74	0.66	1.18	1.4	0.85	2.45	2.65	Upgrade
Other Operating Activities	2.2	-0.4	-0.48	0.2	1.82	-1.53	-0.41	-8.16	-0.9	1.84	Upgrade
Operating Cash Flow	-10.07	-11.4	-9.25	-8.66	-8.65	-8.75	-8.2	-14.4	-21.86	-24.54	Upgrade
Capital Expenditures	-0.05	-0.15	-0.19	-0.07	-0.06	-0.04	-0.01	-0.75	-0.65	-0.13	Upgrade
Acquisitions	0	0	0	0	0	0	0	10.32	0.04	0	Upgrade
Change in Investments	1.99	8.68	-4.39	-0.58	-2.95	-2.75	0	0	0	11.51	Upgrade
Other Investing Activities	-	-	-	-	-	-	-	0.19	-	0.29	Upgrade
Investing Cash Flow	1.95	8.52	-4.58	-0.65	-3.02	-2.79	-0.01	9.75	-0.61	11.67	Upgrade
Share Issuance / Repurchase	5.95	0	15.85	6.96	14.08	0.12	15.28	0	14.7	25.21	Upgrade
Debt Issued / Paid	0.97	0	0	0.33	0	0	0	0	0	0	Upgrade
Other Financing Activities	-0.04	-0.04	-0.1	-0.02	-0	-0.01	-0.01	-0.3	-	-	Upgrade
Financing Cash Flow	6.87	-0.04	15.75	7.28	14.08	0.12	15.27	-0.3	14.7	25.21	Upgrade
Exchange Rate Effect	-0.04	-0.05	-0.01	-0.04	-0.02	-0.03	-0	-0.01	-0	-0	Upgrade
Net Cash Flow	-1.29	-2.97	1.91	-2.06	2.39	-11.45	7.06	-4.96	-7.78	12.35	Upgrade
Free Cash Flow	-10.11	-11.56	-9.44	-8.73	-8.72	-8.8	-8.21	-15.16	-22.52	-24.67	Upgrade
Free Cash Flow Margin	-16856.67%	-2568.44%	-1537.79%	-1091.99%	-1081.27%	-1582.01%	-869.49%	-1307.68%	-1667.93%	-880.89%	Upgrade
Free Cash Flow Per Share	-1.27	-2.35	-2.00	-3.68	-23.88	-35.42	-99.83	-217.98	-360.17	-963.24	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).